![Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10<br/>Lane 2: Human cell line RT-4<br/>Lane 3: Human cell line U-251MG sp<br/>Lane 4: Human plasma (IgG/HSA depleted)](https://cdn11.bigcommerce.com/s-ydswqc5qsc/images/stencil/500x659/products/93554/170312/atl-hpa046269_anti-c8g-pab-atl-hpa046269_51964__44343.1681123969.jpg?c=2 "Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10<br/>Lane 2: Human cell line RT-4<br/>Lane 3: Human cell line U-251MG sp<br/>Lane 4: Human plasma (IgG/HSA depleted)")
Application: WB, IHC
Clonality: Polyclonal
Host: Rabbit
Reactivity: Human
Protein Description: complement component 8, gamma polypeptide
Gene Name: C8G
Alternative Gene Name:
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000015083: 81%, ENSRNOG00000028701: 78%
Entrez Gene ID: 733
Uniprot ID: P07360
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Clonality: Polyclonal
Host: Rabbit
Reactivity: Human
Protein Description: complement component 8, gamma polypeptide
Gene Name: C8G
Alternative Gene Name:
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000015083: 81%, ENSRNOG00000028701: 78%
Entrez Gene ID: 733
Uniprot ID: P07360
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Cognate Antibody/Antigen for Anti C8G pAb (ATL-HPA046269) | |
| Antigen | PrEST Antigen C8G (ATL-APrEST83736) |
| Documents & Links for Anti C8G pAb (ATL-HPA046269) | |
| Datasheet | Anti C8G pAb (ATL-HPA046269) Datasheet (External Link) |
| Vendor Page | Anti C8G pAb (ATL-HPA046269) at Atlas |
| Documents & Links for Anti C8G pAb (ATL-HPA046269) | |
| Datasheet | Anti C8G pAb (ATL-HPA046269) Datasheet (External Link) |
| Vendor Page | Anti C8G pAb (ATL-HPA046269) |
| Citations for Anti C8G pAb (ATL-HPA046269) – 1 Found |
| Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. Eur Respir J. 2022 Feb 17;59(2):2100142. doi: 10.1183/13993003.00142-2021. Print 2022 Feb. PubMed |